Press Release

December 3, 2014
Verastem to Participate in Upcoming Investor Conferences

BOSTON--(BUSINESS WIRE)--Dec. 3, 2014-- Verastem, Inc. (NASDAQ:VSTM), focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, today announced that the company will participate at the following upcoming investor conferences:

  • 25th Annual Oppenheimer Healthcare Conference on Wednesday, December 10, 2014 at 10:20 a.m. ET at The Crowne Plaza Hotel in New York City
  • Guggenheim Securities Boston Healthcare Conference (1x1 meetings only) at the Langham Hotel in Boston

A live webcast of the Oppenheimer presentation can be accessed by visiting the investors section of the Company’s website at www.verastem.com. A replay will be archived on the Verastem website for 90 days following the presentation date.

About Verastem, Inc.

Verastem, Inc. (NASDAQ:VSTM) is discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells. Cancer stem cells are an underlying cause of tumor recurrence and metastasis. Verastem is developing small molecule inhibitors of signaling pathways that are critical to cancer stem cell survival and proliferation: FAK, PI3K/mTOR and Wnt. For more information, please visit www.verastem.com.

Source: Verastem, Inc.

Verastem, Inc.
Brian Sullivan, 617-252-9314
bsullivan@verastem.com